Study on the clinical application, norms, and standards of virtual reality rehabilitation training system for motor-daily activities ability

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100052133

Enrollment

Unknown

Registered

2021-10-20

Start date

2021-10-18

Completion date

Unknown

Last updated

2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stroke

Interventions

experiment group:conventional motor rehabilitation training + NeuCir-VR

control group:conventional rehabilitation training +VR

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with stroke by clinical assessment and comprehensive imaging examinations meet the diagnostic criteria for stroke; 2. Motor dysfunction confirmed by Fugl-Meyer motor function score; 3. Aged 18 to 70 years, male or female; 4. No cognitive impairment or communication impairment, with a score of 27 or above on the Mini-Mental State Examination (MMSE); 5. The first onset, the course of the disease is less than 6 months.

Exclusion criteria

Exclusion criteria: 1. Those with severe systemic diseases such as cardiopulmonary disease who cannot tolerate rehabilitation treatment; 2. Patients diagnosed with mental illness, major depressive disorder (suicidal tendencies) or epilepsy, and those with a family history of mental illness or epilepsy; 3. There are serious systemic diseases such as diabetes and uremia; 4. Severe joint contractures; 5. Suffering from any cause of disorder of consciousness; 6. According to the safety guidelines, there are contraindications for transcranial direct current/magnetic stimulation (TMS/tDCS) and functional magnetic resonance (fMRI) examinations, such as: metal foreign bodies or other implanted electronic devices in the body; 7. Hearing or visual impairment may affect assessment and virtual reality rehabilitation; 8. Use of drugs that change the excitability of the cerebral cortex (anti-epileptic drugs, sedative-hypnotic drugs, etc.).

Design outcomes

Secondary

Measure	Time frame
Electrophysiological examination of upper and lower limbs of affected side;Fugl-meyer balance function score;the functional magnetic resonance imaging (fMRI);mini-mental state examination;modified Ashworth score;Daily life (behavior) ability;Upper limb motor function;Lower limb motor function;Body balance;	—

Primary

Measure	Time frame
change of Fugl-meyer motor function score;	—

Countries

China

Contacts

Public ContactXu Jianguang

Shanghai University of Traditional Chinese Medicine

xjg@shutcm.edu.cn+86 21 51322091

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 10, 2026